UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2125-2132

2017

Volltextzugriff (PDF)

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087

Blood, 2019-10, Vol.134 (14), p.1144-1153

2019

Volltextzugriff (PDF)

Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma

International journal of molecular sciences, 2023-09, Vol.24 (17), p.13187

2023

Volltextzugriff (PDF)

The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects

International journal of molecular sciences, 2023-09, Vol.24 (18), p.14110

2023

Volltextzugriff (PDF)

Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab

Cancers, 2022-04, Vol.14 (8), p.1917

2022

Volltextzugriff (PDF)

Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective

BMC cancer, 2020-11, Vol.20 (1), p.1088-14, Article 1088

2020

Volltextzugriff (PDF)

Thrombocytosis

Blood, 2024-04, Vol.143 (17), p.1782-1782

2024

Volltextzugriff (PDF)

Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers

Medicina (Kaunas, Lithuania), 2022-09, Vol.58 (10), p.1331

2022

Volltextzugriff (PDF)

Relapsed or refractory classical Hodgkin lymphoma: which immunotherapy, and when?

The lancet oncology, 2021-04, Vol.22 (4), p.417-419

Vassilakopoulos, Theodoros P

2021

Volltextzugriff (PDF)

Rapidly deteriorating B-CLL at presentation: clonally related Burkitt leukemia as an atypical Richter transformation?

Blood, 2021-04, Vol.137 (16), p.2272-2272

2021

Volltextzugriff (PDF)

H10: Long-Term Results Could Be Misleading Without an Updated Reading Key for Positron Emission Tomography

Journal of clinical oncology, 2024-06, Vol.42 (18), p.2236-2237

2024

Volltextzugriff (PDF)

Treatment of splenic marginal zone lymphoma

Best practice & research. Clinical haematology, 2017-03, Vol.30 (1-2), p.139-148

2017

Volltextzugriff (PDF)

Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies

Therapeutic Advances in Hematology, 2020, Vol.11, p.2040620720902911

2020

Volltextzugriff (PDF)

Toward a paradigm shift in prognostication and treatment of early‐stage Hodgkin lymphoma

British journal of haematology, 2024-09, Vol.205 (3), p.823-832

2024

Volltextzugriff (PDF)

Very Early Onset of Therapy-Related Acute Myeloid Leukemia with 11q23 Rearrangement Presenting with Unusual PET Findings after R-DA-EPOCH for Primary Mediastinal Large B-Cell Lymphoma

Medicina (Kaunas, Lithuania), 2022-01, Vol.58 (1), p.48

2022

Volltextzugriff (PDF)

TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece

Medicina (Kaunas, Lithuania), 2021-08, Vol.57 (8), p.827

2021

Volltextzugriff (PDF)

A novel immunological assay for hepcidin quantification in human serum

PloS one, 2009-02, Vol.4 (2), p.e4581-e4581

2009

Volltextzugriff (PDF)

Comment on "Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial"

Haematologica (Roma), 2015-11, Vol.100 (11), p.e480-e481

2015

Volltextzugriff (PDF)

Symptomatic ovarian involvement as the initial presentation of primary mediastinal large b-cell lymphoma

Gynecologic oncology reports, 2022-06, Vol.41, p.100988, Article 100988

2022

Volltextzugriff (PDF)

A Unique Case of Primary Extranodal Marginal Zone Lymphoma of the Anal Canal

Acta haematologica, 2019-01, Vol.142 (2), p.87-91

2019

Volltextzugriff (PDF)

Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma

British journal of haematology, 2007-05, Vol.137 (3), p.240-243

2007

Volltextzugriff (PDF)

Senescence and senotherapeutics: a new field in cancer therapy

Pharmacology & therapeutics (Oxford), 2019-01, Vol.193, p.31-49

2019

Volltextzugriff (PDF)

c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma

Human pathology, 2014-03, Vol.45 (3), p.565-572

2014

Volltextzugriff (PDF)

1 – 25 von 286

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(244)

Publikationsform

Sprache

Englisch
(286)

Erscheinungsjahr

n.n

Thema

Science & Technology
(189)
Life Sciences & Biomedicine
(187)
Humans
(149)
Hematology
(112)
Oncology
(98)
Male
(96)
Female
(92)
Middle Aged
(77)
Aged
(74)
Adult
(70)
Prognosis
(49)
Lymphoma
(44)
Aged, 80 And Over
(41)
Treatment Outcome
(38)
Biological And Medical Sciences
(32)
Medical Sciences
(31)
Adolescent
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(27)
Hodgkin Lymphoma
(24)
Retrospective Studies
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087

Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma

The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects

Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab

Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective

Thrombocytosis

Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers

Relapsed or refractory classical Hodgkin lymphoma: which immunotherapy, and when?

Rapidly deteriorating B-CLL at presentation: clonally related Burkitt leukemia as an atypical Richter transformation?

A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and CTLA4 -Mediated Immune Dysregulation Syndrome in Greece

H10: Long-Term Results Could Be Misleading Without an Updated Reading Key for Positron Emission Tomography

Treatment of splenic marginal zone lymphoma

Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies

Toward a paradigm shift in prognostication and treatment of early‐stage Hodgkin lymphoma

Very Early Onset of Therapy-Related Acute Myeloid Leukemia with 11q23 Rearrangement Presenting with Unusual PET Findings after R-DA-EPOCH for Primary Mediastinal Large B-Cell Lymphoma

TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece

A novel immunological assay for hepcidin quantification in human serum

Comment on "Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial"

Symptomatic ovarian involvement as the initial presentation of primary mediastinal large b-cell lymphoma

A Unique Case of Primary Extranodal Marginal Zone Lymphoma of the Anal Canal

Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma

Senescence and senotherapeutics: a new field in cancer therapy

Thioredoxin-1, chemokine (C-X-C motif) ligand-9 and interferon-γ expression in the neoplastic cells and macrophages of Hodgkin lymphoma: clinicopathologic correlations and potential prognostic implications

c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma

Suchergebnisse filtern